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Transcriptome of adult stem cells <p>Comparison of the transcriptomes of pluripotent embryonic stem cells, multipotent adult progenitor cells and lineage restricted mes- enchymal stem cells identified a unique gene expression profile of multipotent adult progenitor cells.</p>
Abstract
Background: Recently, several populations of postnatal stem cells, such as multipotent adult
progenitor cells (MAPCs), have been described that have broader differentiation ability than
classical adult stem cells. Here we compare the transcriptome of pluripotent embryonic stem cells
(ESCs), MAPCs, and lineage-restricted mesenchymal stem cells (MSCs) to determine their
relationship.
Results: Applying principal component analysis, non-negative matrix factorization and k-means
clustering algorithms to the gene-expression data, we identified a unique gene-expression profile
for MAPCs. Apart from the ESC-specific transcription factor Oct4 and other ESC transcripts, some
of them associated with maintaining ESC pluripotency, MAPCs also express transcripts
characteristic of early endoderm and mesoderm. MAPCs do not, however, express Nanog or Sox2,
two other key transcription factors involved in maintaining ESC properties. This unique molecular
signature was seen irrespective of the microarray platform used and was very similar for both
mouse and rat MAPCs. As MSC-like cells isolated under MAPC conditions are virtually identical to
MSCs, and MSCs cultured in MAPC conditions do not upregulate MAPC-expressed transcripts, the
MAPC signature is cell-type specific and not merely the result of differing culture conditions.
Conclusion: Multivariate analysis techniques clustered stem cells on the basis of their expressed
gene profile, and the genes determining this clustering reflected the stem cells' differentiation
potential in vitro. This comparative transcriptome analysis should significantly aid the isolation and
culture of MAPCs and MAPC-like cells, and form the basis for studies to gain insights into genes
that confer on these cells their greater developmental potency.
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Background
Multiple types of adult stem cell exist, of which the hemat-
opoietic stem cell (HSC), which gives rise to cells of all hemat-
opoietic lineages for the life of an animal, is the best
characterized [1,2]. Other adult stem cells include neural
stem cells (NSCs) [3], and the mesenchymal stem cells
(MSCs) that give rise to osteoblasts, chondrocytes, adi-
pocytes, and skeletal and smooth muscle myocytes [4]. In
contrast to embryonic stem cells (ESCs), which can give rise
to all cell types in an adult organism and are called pluripo-
tent [5], HSCs, MSCs, and NSCs are termed multipotent. A
number of recent studies have suggested that cells with more
pluripotent features than HSCs, MSCs, or NSCs can be iso-
lated from postnatal somatic tissues. Reyes [6] and Jiang [7]
described a population of cells termed multipotent adult pro-
genitor cells (MAPCs), which expand in vitro without obvious
senescence, and can, at the clonal level, not only generate
mesenchymal-lineage cells but also endothelium, hematopoi-
etic cells, hepatocyte-like, and neuroectoderm-like cells in
vivo and/or in vitro. Since the characterization of MAPCs,
several other groups have described cells with similar abilities
that can be isolated from bone marrow (human bone marrow
stem cells (hBMSC), marrow-isolated adult multilineage
inducible (MIAMI) cells, and pre-MSCs), umbilical cord
blood (unrestricted somatic stem cells (USSCs)), placenta,
muscle, and other tissues [8-13].
Despite the greater differentiation potential of the more
pluripotent cells, such as MAPCs, compared with MSCs, it is
not known whether MAPCs are different from classical post-
natal MSCs. It is also not known how closely MAPCs resemble
ESCs. We therefore applied principal components analysis
(PCA), non-negative matrix factorization (NMF) and k-
means clustering to analyze their transcriptomes and deter-
mine the relationship between MAPCs, MSCs and ESCs,
using mouse and rat MAPCs and mouse MSCs and ESCs.
Results
Isolation and characterization of mouse and rat 
MAPCs
Mouse (m) MAPCs and rat (r) MAPCs were isolated from
marrow of C57BL/6-Tg-eGFP mouse and Fisher rats under
5% oxygen as recently described [14]. Two independently and
clonally isolated mMAPC populations - mMAPC-1 and
mMAPC-2 - expressed the mRNA for the transcription factor
Oct4 at a level of 4-10% of the Oct4 RNA levels in mouse ESCs
or at a difference in threshold cycles (ΔCT) of 6 to 8 compared
with the mRNA for glyceraldehyde-3-phosphate dehydroge-
nase (Gapdh) (Figure 1a). Similarly, rMAPCs isolated under
these conditions expressed high levels of Oct4 mRNA (ΔCT of
1 to 2 compared with Gapdh mRNA, Figure 1a). We have
recently found that both mouse and rat MAPCs express Oct4
protein, which is localized in the nucleus [14]. However,
whereas some clones isolated under MAPC culture conditions
express Oct4 (mMAPC-1, -2 and rMAPC-1), other clones
(mClone-3 and rClone-2 obtained in the same isolation as
mMAPC-1 and rMAPC-1, respectively) do not express Oct4
(Figures 1a and 2b). The transcription factor Oct4 (Pou5f1) is
expressed in early embryonic development and is essential
for the maintenance of the pluripotent state of ESCs [15].
Although it has generally been accepted that Oct4 expression
in adults is restricted to primordial germ cells, recent studies
have shown that Oct4 mRNA and/or protein can be detected
in bone marrow cells following in vitro culture [7,10,16,17],
and may be expressed in some cells from bone marrow iso-
lates [18,19].
The cell-surface phenotypes of mouse mMAPC-1, mMAPC-2,
and mMSC (obtained from D. Prockop, Tulane University)
are shown in Figure 2a. MAPCs and MSCs are negative for the
hematopoietic marker CD45. MAPCs, but not MSCs, express
c-Kit and are negative for CD34 and Sca-1. Both populations
express CD44, although MSCs express it at higher levels. Oct4
protein is homogeneously detected in both mMAPC popula-
tions at lower levels than in ESCs, but is absent in mMSCs
(Figure 2a). Like the phenotype of mMAPCs, the phenotype of
rMAPCs is homogeneous. rMAPCs express Oct4 and CD31,
whereas rClone-2 expresses neither (Figure 2b). Karyotyping
of the two mMAPC clones and rClone-2 showed that at least
65% of the cells were diploid, whereas 95% of the rMAPC-1
population was diploid. Both the mClone-3 and mMSCs con-
tained less than 20% diploid karyotype.
The two mMAPC clones and the rMAPC clone were evaluated
for their ability to differentiate in vitro towards endothelium-,
hepatocyte- and neuroectoderm-like cells. Both mMAPC and
rMAPC clones cultured for 9 days in the presence of vascular
endothelial growth factor A (VEGF-A) showed a significant
increase in transcript levels of lymphatic endothelial-associ-
ated genes (for example, Lyve-1) and endothelial markers
(von Willebrand factor (vWF), CD31, vascular endothelial
cadherin (VE-cadherin), and the VEGF receptors Flt-1 and
Flk-1) (see Figure 1b). MAPC-derived progeny also acquired
functional characteristics of endothelium as they form vascu-
lar tubes and take up acetylated low-density lipoprotein (ac-
LDL) (A.L. and C.M.V., unpublished work). Moreover, we
have evidence that the mMAPCs used here generate HSCs in
vivo that reconstitute the lympho-hematopoietic system [20],
and when grafted into the limbs of mice with limb ischemia
induce significant recovery of perfusion and muscle function
within 3 weeks, in part due to the incorporation of MAPC
progeny into endothelium, smooth muscle and skeletal mus-
cle in the ischemic limb (A.L. and C.M.V., unpublished work).
Of note, we did not see formation of tumors from mMAPCs in
these transplantation experiments. When MAPCs were cul-
tured with bone morphogenetic factor 4 (BMP4), the fibrob-
last growth factors FGF2 and FGF8, hepatocyte growth factor
(HGF), oncostatin M (OSM), and dexamethasone, a signifi-
cant induction of the mRNAs for alfafetoprotein (Afp), tran-
sthyretin (Ttr), tyrosine aminotransferase (Tat), albumin
(Alb) and coagulation factor 2 (F2) was seen (Figure 1c).http://genomebiology.com/2007/8/8/R163 Genome Biology 2007,     Volume 8, Issue 8, Article R163       Ulloa-Montoya et al. R163.3
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MAPC-derived progeny also acquired functional characteris-
tics of hepatocyte-like cells, as they secrete albumin and con-
jugate billirubin (K.A.P. and C.M.V., unpublished work).
Finally, mouse or rat MAPCs cultured at low density in N2/
B27 medium [21] express transcripts specific for neuroecto-
derm, including Sox2, Sox1 and Pax6, as well as Sox2 and
Pax6 protein (A.C., M.G. and C.M.V., unpublished work).
These results together show that MAPCs have a much broader
differentiation capacity compared with MSCs. Mouse MSCs
differentiated into osteoblast and adipocyte progeny (as
described by Peister et al. [22], data not shown).
Transcriptome analysis of mMAPCs compared with 
MSCs and ESCs
In a first set of studies we compared the transcriptomes of the
two mMAPC clones (mMAPC-1 and -2), C57BL/6 mouse
MSCs, and C57BL/6 mouse ESCs. All cell populations were
harvested during log-phase of expansion, that is, 2-3 days
after subculturing, to avoid differences in expression data due
to differences in cell-cycle state. Three samples of RNA for
each cell type were collected at different passages for gene-
expression profiling using Affymetrix Mouse 430 2.0 arrays.
We observed little variation in gene expression over time, as
Oct4 expression and endothelial-like and hepatocyte-like differentiation for mMAPC-1, mMAPC-2, mClone-3, rMAPC, and rClone-2 Figure 1
Oct4 expression and endothelial-like and hepatocyte-like differentiation for mMAPC-1, mMAPC-2, mClone-3, rMAPC, and rClone-2. (a) The levels of 
Oct4 (Pou5f1) mRNA in mouse (m, left) and rat (r, right) clones compared with those of Gapdh mRNA. The mouse clones are also compared with mESCs. 
ΔCT is difference in threshold cycles calculated as Oct4 CT - Gapdh CT. ND, not detected. (b) Endothelial-like differentiation. mRNA levels of endothelial 
markers in mouse (left panel) and rat (right panel) clones before and after differentiation, measured at day 9 in two independent differentiations of each 
clone. Levels are compared with those in universal mouse RNA and rat spleen RNA, respectively. Left panel: blue diamonds, Pecam (×10) (values shown 
were scaled by the factors in brackets); pink squares, Lyve1; orange triangles, vWF. Right panel: blue diamonds, VE-Cad (×100); pink squares, Flt-1; orange 
triangles, Flk-1; turquoise crosses, vWF (×100). (c) Hepatocyte-like differentiation. mRNA levels of hepatocyte markers in mouse and rat clones before 
and after differentiation. Levels are compared with levels in mouse hepatocytes and rat liver, respectively. Two representative differentiations measured at 
day 18 are shown. Left panel: blue diamonds, F2 (×100); pink squares, Tat, (×105); green triangles, Afp (×10-1); turquoise crosses, Ttr (×103). Right panel: 
blue diamonds, Afp (×100-1); pink squares, Alb, (×103); orange triangles, Tat (×100); turquoise crosses, Ttr (×103). See text for abbreviations.
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Figure 2 (see legend on next page)
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the correlation coefficients of probe-set intensity values
between the replicates were at least 0.98. The average of the
expression levels from the three replicates were used for anal-
ysis and genes with twofold difference in expression levels
between any pair of cell types (MAPC clones were treated
individually) and with a false-discovery rate (FDR) of less
than 0.5% (evaluated using significance analysis of microar-
rays (SAM) [23]) were considered as differentially
expressed). This resulted in 9,702 differentially expressed
transcripts. PCA was used to reduce the dimensionality of the
expression dataset and represent it as a linear combination of
two main orthogonal variables (principal components, PCs)
[24,25] (PCA is a dimensionality-reduction technique based
on singular value decomposition of the covariance matrix that
allows expression and visualization of genes or samples in a
reduced components space defined by the PCs). Figure 3a
shows that the first two PCs captured 95% of the total vari-
ance. Plotting samples in this two-PC-reduced dimensional
space demonstrated clear separation of the mMAPC popula-
tions, ESCs, and MSCs into three distinct groups (Figure 3b).
We used NMF to group samples and genes according to the
major patterns of expression in the dataset (metagenes) [26].
NMF is based on a linear decomposition of the expression
data into two matrices with non-negative entries and allows
representation of the expression data in a k-dimensional
space where k is the number of groups or 'metagenes'. The
optimal number of clusters is determined after a consensus
matrix is built on the basis of the metagene expression pat-
tern of each sample. We found that the best grouping, defined
as the consensus matrix where probability entries are either 0
or 1, is with k = 3 groups or metagenes (Figure 3c). Through
NMF, those samples were also separated into three groups:
MSCs, mMAPCs, and ESCs. Correlation coefficients of genes
to each metagene were calculated for gene clustering. The
expression profiles of those three metagenes are shown in
Figure 3d. Metagene 1 (consisting of 2,304 genes) is highly
expressed in ESCs and low or not expressed in mMAPCs or
MSCs; metagene 2 (consisting of 2,442 genes) is highly
expressed in MSCs and low or not expressed in mMAPCs or
ESCs; and metagene 3 (consisting of 1,551 genes) is highly
expressed in mMAPCs but low in ESCs and MSCs.
Among the 1,551 genes in metagene 3, 546 genes were more
than twofold differentially or uniquely expressed in mMAPCs
(Figure 4a,b and Additional data file 1). mMAPCs expressed
transcripts for a set of transcription factors that are expressed
during specification to extraembryonic, primitive, or defini-
tive endoderm during embryonic development. These include
Sox17, Foxa2, Gata6, Gata4, Sox7, Hnf4α, Cited1, and Tcf2.
Also expressed were transcripts of laminin Lamb1, the adap-
tor protein Dab2 and other basement membrane components
such as LamA1,  LamA4,  Lamc1,  Col4a1, and Nidogen 2.
Some of these genes (Lamb1, Dab2) are known to be induced
by Gata6 [27,28]. This expression pattern is also seen in
primitive endoderm and extraembryonic endoderm cell lines
(XEN cells) [29,30], and can be induced in ESCs or in the
in ne r cell  mass  ( IC M)  by  kn ock ing  o ut  or  dow nr eg u la tin g
expression of Nanog [31-33]. This is consistent with the fact
that even though mMAPCs express Oct4 mRNA they do not
express  Nanog. In addition, mMAPCs also uniquely
expressed transcripts of a small number of mesodermal tran-
scription factors, such as Tefc, Myocd, Pitx2, and Mitf, at lev-
els significantly higher than in MSCs and ESCs. A number of
these genes were chosen for quantitative real-time PCR (Q-
RT-PCR) on unamplified RNA for confirmation of the micro-
array results (Figure 5).
A set of 757 genes have expression levels in both mMAPCs
and ESCs at least twofold higher than in MSCs (Figure 4c,d
and Additional data file 1). We explored the levels of tran-
scripts that are found to be specifically expressed in mouse
ESCs in other studies; it should be noted that some of these
genes might not be implicated in maintaining the ESC state.
The degree of expression of such genes in MAPCs or MSCs
per se also does not prove that one or the other cell popula-
tions is more related to ESC. An extensive search for ESC-spe-
cific transcripts was performed by Mitsui et al. [31] by in silico
differential expression. This approach yielded a list of 20
genes that are enriched in ESCs, named ESC-associated tran-
scripts (Ecats), corroborated Oct4 and Rex1 (Zfp42) as ESC
markers, and identified Nanog as required for maintaining
ESC pluripotency. Six out of 20 Ecats were expressed in both
ESCs and mMAPCs (Sall4,  Dnmt3l,  Dppa5,  Fbxo15,  Rex1
(Zfp42) and Oct4 (Pou5f1)). Two Ecats (Zfp296 and Ecat6)
were expressed in mMAPCs and in MSCs, although at lower
levels, whereas another two Ecats (Eras, Utf1) were expressed
only at low levels in mMAPC-2 and not in mMAPC-1. This was
seen in the microarray assay and was confirmed by Q-RT-
PCR on unamplified RNA as shown in Figure 5a, whereas the
final 10 Ecats (Ecat1, Tcl1, Tdgf1, Nanog, Ecat8, Nr0b1, Gdf3,
Map3k8 or Est, Hnrnpg-t and Brachyury (T-box)) were not
expressed in mMAPCs and their absence has been confirmed
by Q-RT-PCR on multiple samples besides the ones used for
microarray assay (Figure 5). Of the six Ecats expressed in
both MAPC clones, Dppa5 and Fbxo15 are dispensable for
maintaining ESC pluripotency [34,35]. Sall4, one of the Ecats
highly expressed in MAPCs, was recently described as
Cell-surface phenotype and Oct4 protein expression of mouse and rat clones evaluated by flow cytometry Figure 2 (see previous page)
Cell-surface phenotype and Oct4 protein expression of mouse and rat clones evaluated by flow cytometry. (a) Flow cytometry results for mouse clones. 
From left to right: MSCs; mMAPC-1; mMAPC-2; mClone-3; and MSCs cultured in MAPC conditions. The histogram in each panel plots the number of cells 
(as a percentage of the maximum) on the vertical axis against the fluorescence intensity of the labeled antibody bound to the indicated protein (horizontal 
axis). The horizontal line on each histogram indicates the fluorescence range that contains the indicated percentage of cells positive for that protein. (b) 
Flow cytometry results for the rat clones rMAPC-1 and rClone-2.R163.6 Genome Biology 2007,     Volume 8, Issue 8, Article R163       Ulloa-Montoya et al. http://genomebiology.com/2007/8/8/R163
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essential for pluripotency in ESCs and early embryonic devel-
opment through its direct regulation of Oct4 transcription
[36,37]. Like the overexpression of Oct4, overexpression of
Sall4 in mouse ESCs directs them to a primitive endoderm
fate when leukemia inhibitory factor (LIF) is withdrawn [36].
Of three additional genes recently implicated in self-renewal
of mouse ESCs [38], Tbx3  was expressed in mMAPCs at
higher levels than in ESCs, Dppa4 at low levels, and Esrrb
expression was not detected in mMAPCs. The α6 integrin
present in the 'stem cell signature' [39-41] was also expressed
in both ESCs and mMAPCs. Klf4 and Mycn (encoding a tran-
scription factor related to c-Myc), which together with Oct4
and Sox2 can induce an ESC-like phenotype in murine fibrob-
lasts, were expressed in both mMAPCs and ESCs [35]. Impor-
tantly, subsequent studies found that fibroblasts into which
the four transgenes had been introduced could produce chi-
meric mice when Nanog expression was activated [42,43]. A
number of transcription factors involved in early embryonic
PCA and NMF analysis of the gene-expression data of mouse MSC, MAPC-1, MAPC-2 and ESC Figure 3
PCA and NMF analysis of the gene-expression data of mouse MSC, MAPC-1, MAPC-2 and ESC. (a) Percentage variation captured in each principal 
component (PC). PCs are ordered from 1 to 4 according to the percentage of the total variance they capture. (b) Samples plotted in the first two 
components' space. Distance of samples in the component space is indicative of similarity in expression profiles. (c) Consensus matrix from NMF. Model 
selection in NMF is based on a consensus matrix that contains the probability that a pair of samples is assigned to the same group. Probability values 
correspond to the colors in the key. M-1, MAPC-1; M-2, MAPC-2; (d) Metagene profiles from NMF plotted as logarithm of the probe set intensity.
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development (Pem, Klf5, Tead2 and Sall1), as well as Lin28,
a gene downregulated during ESC differentiation [44], Tex19,
a testis-specific transcription factor [45] and several mem-
bers of the Bex family (some of them involved in neural differ-
entiation - Rex3, Bexl1, and Bex2 [46]) were coexpressed in
mMAPCs and ESCs.
Genes highly expressed in ESCs at levels at least twofold those
in MSCs and mMAPCs include genes for 93 transcription fac-
tors. One of these was Sox2, which, like Nanog and Oct4, is
required for the pluripotent character of ESCs [47]. Genes
such as Fgf4 (a target gene for Oct4 and Sox2 [48]), Nodal
and Lefty [49], which all encode well-known ESC-expressed
secreted factors, were not expressed in mMAPCs or MSCs.
Eight hundred genes were coexpressed between MSCs and
mMAPCs at levels at least twofold higher than in ESCs (Fig-
ure 4e,f and Additional data file 1). These included genes for
37 transcription factors, most of which play a role in early
mesoderm development, including Meis1,  Hoxa1,  Lhx6,
Runx1, and Msx2. A similar early endoderm phenotype is
seen when mMAPCs are compared with ESCs using long-oli-
gonucleotide arrays
To substantiate the results obtained using the Affymetrix
platform and confirm that the genes associated with MAPCs
and MAPCs/ESCs were not the result of the cell type to which
they were compared (that is, MSCs) or of the array platform
used, we compared the transcriptomes of mMAPC-1 and
ESCs to an enriched, although not pure, neural progenitor
population, namely neurospheres (NS) derived from embry-
onic day 11.5 mouse brain. This analysis was performed by
hybridization on long-oligonucleotide arrays (National
Institute on Aging (NIA) Mouse 44 K Microarray v2.1 slides;
Whole Genome 60-mer oligo) in comparison with universal
RNA. Genes with a twofold difference in expression and an
F D R  o f  l e s s  t h a n  5 %  w e r e  c o n s idered to be differentially
expressed. Using k-means clustering, we found that six clus-
ters capture the major patterns in data variability among
these samples.
A cluster containing 775 genes expressed in mMAPCs at levels
at least twofold higher than in both ESCs and NS was identi-
fied (Figure 6c,d and Additional data file 1), with many of
these genes functioning or being transcribed during endo-
derm specification, including Gata4,  Gata6,  Sox7,  Sox17,
Cited1, Lamb1, LamA1, LamA4, Col4a1, Dab1, Nidogen 2 and
Afp. Of the 38 transcription factors enriched in mMAPCs, we
found the mesodermal transcription factors Pitx2 and Mitf,
also identified in the ESC-MAPC-MSC comparison, to be
most highly expressed in mMAPCs. Additional mesodermal
transcription factors expressed in mMAPCs include Hmx1,
Hmx2, Hoxa1, and Msx2. When the same analysis was done
simply comparing genes differentially expressed between
MAPCs and ESCs, without NS as a comparator, a similar
expression pattern emerged. Within the genes expressed at
more than twofold higher levels in MAPCs compared with
ESCs and with an FDR of less than 5%, we again identified the
genes functioning or being transcribed during endoderm
specification as well as early mesodermal transcription fac-
tors (Additional data file 1).
Five hundred and thirty genes were expressed in mMAPCs
and ESCs at levels at least twofold higher than in NS (Figure
6a,b and Additional data file 1). Of the 20 Ecats, three
(Dnmt3l, Fbxo15, and Sall4) were more highly expressed in
mMAPC-2 than in ESCs or NS, and four (Oct4 (Pou5f1), Rex-
1  (Zfp42),  Dppa5, and Zfp296) were highly expressed in
mMAPC-2 and ESCs, although ESCs expressed these genes at
levels at least twofold higher than mMAPCs. Low levels of
Utf1,  Eras,  Hnrnpg, and Gdf3  transcripts were found in
mMAPC-2; the former two were confirmed by Q-RT-PCR
(Figure 5a,b). Eight Ecats - Ecat1,  Ecat8,  Nanog,  Nr0b1,
Brachyury,  Map3k8  (EST),  Tcl1, and Tdgf1  - were not
expressed at significant levels in mMAPCs, and Ecat6 was not
found on the NIA array. Expression of Ecat genes and other
ESC-enriched genes in mMAPCs compared with ESCs is con-
sistent with the Affymetrix microarray. When the analysis
was done without NS as comparator, a similar picture
emerged (Additional data file 1).
Among the 530 genes expressed in mMAPCs and ESCs at lev-
els at least twofold higher than in NS, a number were also
more highly expressed in ESCs and MAPCs than in MSCs in
the Affymetrix analysis, including Tbx3, Tbx15, Taf4b, Tcf3,
Nmyc, Taf7, Klf4, Klf5, Klf8, and the Oct4-regulated gene
Dppa2 [50]. Consistent with the ESC/MAPC/MSC analysis,
Dppa4, Lefty, Fgf4, and Nodal were uniquely expressed in
ESCs in the ESC/MAPC/NS analysis.
The agreement of the results obtained by both the Affymetrix
and the NIA microarray platforms was corroborated by com-
paring clusters of genes expressed in MAPCs or coexpressed
between MAPCs and another cell type (ESC, MSC, or NSC)
obtained from both platforms. This analysis demonstrated
that more than 65% of genes expressed in MAPCs in either
analysis were identical, even though gene assignment to clus-
ters was somewhat different in the ESC/MAPC/MSC versus
ESC/MAPC/NS analysis as a result of the differences between
MSCs and NS. One hundred and forty-nine genes found to be
expressed at significantly higher levels in mMAPCs compared
with NS and ESCs with the NIA array were also significantly
expressed in MSCs falling into the MAPC/MSC cluster in the
Affymetrix dataset. These include genes for mesodermal tran-
scription factors such as Hoxa1, Msx2, and Cited2. Similarly,
132 genes coexpressed between MAPCs and ESCs at higher
levels than in NS in the NIA dataset were not differentially
expressed when compared to MSCs and were not assigned to
the MAPC/ESC cluster in the MAPC/ESC/MSC comparison.
Taking these factors into consideration, 349/550 and 257/
379 genes more highly expressed in mMAPCs and in both
mMAPCs and ESCs, respectively, in the NIA dataset were alsoR163.8 Genome Biology 2007,     Volume 8, Issue 8, Article R163       Ulloa-Montoya et al. http://genomebiology.com/2007/8/8/R163
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more highly expressed in MAPCs, or showed similar expres-
sion in MAPCs and ESCs, in the Affymetrix dataset, and are
therefore likely to represent the mMAPC molecular signature
(Additional data file 1).
The mesendodermal mMAPC signature is not induced 
by the culture medium
One possible explanation for the differences in the mMAPC
and MSC transcriptomes could be the differences in culture
conditions used in their isolation and expansion (2% serum,
platelet derived growth factor (PDGF)-BB, epidermal growth
factor (EGF) and LIF for mMAPCs and 10% FCS plus 10%
horse serum for MSCs). We therefore compared the tran-
scriptomes of MAPCs, ESCs, and MSCs with that of mClone-
3, which was isolated under conditions used to isolate
mMAPC. mClone-3 did not express Oct4 mRNA and differen-
tiated poorly into endothelial or hepatocyte-like cells (Figure
1a-c). Moreover, we have shown that cells with low levels of
Oct4 do not generate HSCs that can repopulate the lympho-
hematopoietic system in vivo [20]. In contrast to mMAPC1
and mMAPC2, mClone-3 expresses the cell-surface antigens
Sca-1 and CD44, but not c-Kit (Figure 2). Using PCA, the non-
Oct4-expressing mClone-3 cells (named MSC-like cells) were
shown to be very similar to MSCs but not to the Oct4-express-
ing mMAPCs (Figure 7a). The first two PCs accounted for
84% of the total variation, whereas the third component that
discriminates between MSC-like cells and MSCs accounted
for only 12% of the variation. NMF analysis similarly demon-
strated that MSC-like cells are closely related to MSCs. The
consensus matrixes obtained by grouping two or three groups
gives elements of only 0 or 1, placing MSCs and MSC-like cells
together in a group (Figure 7b). Seven hundred and forty-
three genes were found to be more than fourfold differentially
expressed between MSC and MSC-like cells, irrespective of
their expression level in the other cell types (Additional data
file 1). Forty-four of the genes more highly expressed in MSCs
than in MSC-like cells were for transcription factors, of which
m o s t  a r e  r e g u l a t o r s  o f  mesoderm development (Dlx5,
Hoxc13, Sox11, Lhx6, and Dlx6) but a few are regulators of
neural development (Emx2) or endoderm/mesoderm devel-
opment (Gata6). Likewise, rare regulators of endoderm
(Pcbd1, whose protein is a dimerization cofactor of HNF1α)
and ectoderm (Sox2, Isl-1) and more regulators of mesoderm
development (Gata2, Hoxa11, Mitf1, Sox5, Sox6 and Cebpδ),
were more highly expressed in MSC-like cells than in MSCs.
Neural cell adhesion molecule (NCAM) and cadherin 11
(Cdh11), which are expressed in MSCs, were not expressed in
MSC-like cells, and Nrcam, Pdgfra, CD24, and Cdh13 were
expressed in MSC-like cells but not in MSCs. One thousand
seven hundred and seventy-two (1,772) transcripts were
expressed in both MSC and MSC-like cells at levels at least
twofold higher than in mMAPCs and ESCs. Transcription fac-
tors in this list have known roles in development and mor-
phogenesis of mesodermal tissue (Hox family members,
Runx2, Cebpβ, Pparγ, and Sox9). Both MSC and MSC-like
cells expressed transcripts for morphogens such as Bmp4,
Bmp1, transforming growth factor beta 3 (TGFβ3), inhibin
beta A (Inhba), PDGF-A, PDGF-C, and Wnt5a. Cell-surface
markers coexpressed in MSCs and MSC-like cells included
CD34, which is known to be expressed on murine MSCs, and
Sca-1 and CD44, which, as mentioned above, discriminates
between mMAPCs and MSC-like cells. Hence, although some
differences could be detected in MSCs and MSC-like cells,
they involve mainly regulators of mesoderm differentiation
and specification, and did not involve genes that define either
ESCs or MAPCs.
To further address the question of whether differences in cul-
ture conditions were responsible for differences in the ESC,
MAPC, and MSC transcriptomes, we carried out PCA on sub-
sets of genes reported to be upregulated by short-term culture
under hypoxic conditions (16 or 24 hours at 1-1.5% O 2) in
mESCs or rat MSCs by Hu et al. [51] (44 genes) and Onhishi
et al. [52] (135 genes), respectively. Neither of these two
subsets of genes separates MAPCs, MSCs, and ESCs (Addi-
tional data file 2). It is notable that none of the endoderm-,
mesoderm- or ESC-associated genes expressed in MAPCs is
more highly expressed in MSCs kept under hypoxic condi-
tions for 24 hours [52].
In a second set of studies, we evaluated the effect of culturing
the MSCs obtained from Tulane University for 15 population
doublings under MAPC conditions (5% O2  and MAPC
medium). The cell-surface phenotype did not change signifi-
cantly, and MSCs cultured under MAPC conditions remained
negative for c-Kit and positive for CD44, Sca-1, and CD34
(Figure 2a). CD34 and Sca1 were more homogeneously
expressed on mMSCs cultured under MAPC conditions, and
more similar to mClone-3, than on mMSCs maintained in
MSC culture conditions (Figure 2a). mMSCs cultured under
MAPC conditions also did not express Oct4 transcripts (as
determined by Q-RT-PCR) or Oct4 protein (as determined by
FACS analysis) (Figure 2b). Finally, using Q-RT-PCR, we
determined whether genes highly expressed in MAPCs but
n o t  i n  M S C s  ( l e s s  t h a n  0 . 1 %  o f  M A P C  e x p r e s s i o n )  w e r e
induced following culture for 14 days under MAPC
Genes for cell-surface and extracellular space proteins and transcriptional regulators clustered according to their expression profiles in the mouse MAPC/ ESC/MSC comparison and in rat rMAPC-1 and rClone-2 Figure 4 (see previous page)
Genes for cell-surface and extracellular space proteins and transcriptional regulators clustered according to their expression profiles in the mouse MAPC/
ESC/MSC comparison and in rat rMAPC-1 and rClone-2. (a, b) Genes expressed in mMAPCs at levels at least twofold higher than in ESCs and MSCs. (c, 
d) Genes expressed in mMAPC/ESCs at levels at least twofold higher than in MSCs. (e, f) Genes expressed in mMAPC/MSCs at levels at least twofold 
higher than in ESCs. (g, h) Genes expressed at levels at least twofold higher in rMAPC-1 than in rClone-2. (i, j) Genes expressed in rClone-2 at levels at 
least twofold higher than in rMAPC-1. The yellow bars indicate genes for proteins localized to the extracellular space; the blue bars indicate genes for 
transcriptional regulators. Red and green indicate higher and lower levels of expression, respectively.R163.10 Genome Biology 2007,     Volume 8, Issue 8, Article R163       Ulloa-Montoya et al. http://genomebiology.com/2007/8/8/R163
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Figure 5 (see legend on next page)
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conditions. Culture of mMSCs in MAPC conditions for 15
doublings did not induce expression of Sox17, Sox7, HNF4α,
Tek, or Myocd (Figure 5a). Similarly, no change was detected
in the expression of Pdgfra (CD140a) at the mRNA or protein
level (Figures 2a and 5a). Pdgfra is, however, one of the genes
more highly expressed in mClone-3 cells than in MSCs, at lev-
els near those seen in mMAPC-1 and mMAPC-2. This sug-
gests that isolation and long-term maintenance of cells under
MAPC rather than MSC conditions might be responsible for
some of the differences in gene expression between MAPCs
and MSCs. We therefore identified the set of genes whose
expression pattern was similar to that of Pdgfra. Only 146
genes were highly correlated or anti-correlated with Pdgfra
(0.85 absolute correlation) suggesting that these genes might
be upregulated or downregulated, respectively, as a result of
MAPC culture conditions (Additional data file 1). Interest-
ingly, this list of genes includes Klf4 and a few endodermal
markers such as Lam4, Col4, and Tcf2. Removal of this subset
of genes from the analysis did not significantly alter sample
clustering by either PCA or NMF (Additional data file 2).
Signature of rat rMAPCs is similar to that of mouse 
mMAPCs
Finally, we evaluated the transcriptomes of one clone of rat
MAPCs (rMAPC-1) expressing high levels of Oct4 mRNA and
protein and one clone of rat cells that expressed 1,000-fold
lower levels of Oct4  mRNA and differentiated poorly into
endothelium or hepatocyte-like cells (rClone-2), even though
it was isolated and cultured under MAPC conditions (Figure
1a-c). The transcriptome was analyzed using Affymetrix Rat
230A arrays, which contain 4,699 known rat sequences and
10,467 expressed sequence tags. Of the 2,869 probes differen-
tially expressed with an FDR of 1.75%, 1,285 were annotated
as unique genes (Additional data file 1). Data from different
species were not compared directly, because only relative
gene expression (ratio of two samples), instead of the abso-
lute abundance of mRNA, is obtained. Thus, we compared
genes differentially expressed between rMAPC-1 and rClone-
2 to those differentially expressed between mMAPC-1,
mMAPC-2, and MSCs. We identified a panel of 585 genes that
were differentially expressed in both the mouse and rat anal-
ysis using Affymetrix arrays. Of these genes, 86% show the
same trend in expression in both datasets; that is, they were
either more highly expressed in the high-Oct4-expressing
rMAPC-1, mMAPC-1, and mMAPC-2, or in cells that do not
express Oct4 - rClone-2 and mouse MSCs (Additional data file
1). The correlation coefficient of 0.7 when we plot the relative
gene-expression levels in the two datasets further confirms
the similarities in the MAPC molecular signature in both
rodent species (Additional data file 2).
A significant number of genes differentially expressed
between rMAPC-1 and rClone-2 encoded transcription
factors. As in mMAPCs, we saw an enrichment in Oct4-
expressing rMAPCs (rMAPC-1) of transcription factors and
extracellular matrix components found in trophectoderm,
primitive endoderm, and definitive endoderm (Foxa2, Gata6,
Gata4, HNF1β, Cited1, Tcf2, Lamb1, Lama1, Lamc1, Col4a1,
and Nidogen 2), as shown in Figure 4g,h and Additional data
file 1. High-Oct4-expressing rMAPCs also expressed tran-
scription factors involved in mesodermal development, simi-
larly to the expression seen in mMAPCs, as well as
transcription factors known to be involved in early develop-
ment, which were also found in the set of genes expressed by
both mMAPCs and mESCs. Similarly to our findings in
mClone-3 (MSC-like cells) isolated using the same conditions
as for MAPC, the low-Oct4-expressing rClone-2 cells chiefly
expressed genes involved in mesoderm development, partic-
ularly those for mesenchymal regulators and markers, includ-
ing Cebpβ, Hoxa5, Shox2, CD105, tensile collagens, and CD44
(Figure 4j). CD44 expression was also observed by flow
cytometry (Figure 2 and Additional data file 1). rClone-2 also
expressed a large number of soluble factors, including those
in the TGFβ family, different VEGFs, Wnt, PDGF, and the
hematopoietic modulators stem-cell factor (SCF) and colony-
stimulating factor (CSF), which are characteristic of stromal
cells such as MSCs. Some of these were also found in mClone-
3 and mMSCs (Figure 4i and Additional data file 1). The sim-
ilarity in expressed gene profile between rClone-2 and mouse
MSCs shows that cells with similar characteristics to MSCs
can be isolated from both mouse and rat using MAPC culture
conditions, and further supports the notion that the major
differences in the expressed gene profile between MAPCs and
MSCs is not caused by differences in the media used to isolate
and/or expand MAPCs.
Discussion
The comparative transcriptome analysis described here dem-
onstrates a unique molecular signature for MAPCs compared
with MSCs. Although both MAPCs and MSCs are isolated
from bone marrow as an adherent cell population, we previ-
ously showed that the differentiation potential of MAPCs far
exceeds that of MSCs [6,7]. Consistent with the notion that
MAPCs are distinct from MSCs, we have used MAPCs from
two rodent species to demonstrate that the MAPC transcrip-
Q-RT-PCR validation of differentially expressed genes Figure 5 (see previous page)
Q-RT-PCR validation of differentially expressed genes. (a) Comparison of relative expression levels of mRNA for the genes indicated by Q-RT-PCR on 
unamplified RNA (black bars) and Affymetrix microarray data (gray bars) (n = 3). Samples were normalized using Gapdh as the housekeeping gene and 
percent expression level was calculated with respect to the highest-expressing sample. The asterisk (*) indicates genes evaluated in mMSCs grown in the 
MAPC condition. (b) Relative mRNA expression levels of Ecats and other ESC-expressed transcripts in mMAPCs (black bars) and ESCs (gray bars) 
quantified using Q-RT-PCR. Three independent isolations of mMAPCs and ESC RNA for Q-RT-PCR were used to confirm microarray mRNA expression 
results. Samples were normalized to ESC expression levels and Gapdh mRNA levels were used for internal normalization.R163.12 Genome Biology 2007,     Volume 8, Issue 8, Article R163       Ulloa-Montoya et al. http://genomebiology.com/2007/8/8/R163
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Figure 6 (see legend on next page)
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tome differs significantly from that of MSCs or MSC-like cells
obtained under the same culture conditions used for MAPC
isolation. The MSC-like cells do not express Oct4 and differ-
entiate poorly towards endothelium- and hepatocyte-like
cells. Furthermore, mouse cells that express very low levels of
Oct4 also cannot generate HSCs when grafted in vivo [20].
We also show that a subset of genes expressed in MAPCs is
also expressed in pluripotent ESCs. For instance, compared
with MSCs, MAPCs express Oct4 transcripts, and Oct4 pro-
tein is present in more than 90% of MAPCs [14]. In addition,
MAPCs express nine other Ecat genes, which were identified
by Mitsui et al. [31] to be ESC-associated, even though not all
of these genes have been found to play a role in maintaining
ESC properties. Moreover, MAPCs express Klf4 and a Myc
family transcription factor, Mycn - which are expressed in
diverse tissues and cell types but have been shown to be
required with Oct4, Sox2 and, indirectly, Nanog for confer-
ring ESC-like characteristics on cultured fibroblasts
[35,42,43]. MAPCs also express the ESC self-renewal
regulators Tbx3 and Dppa4 [38]. Obviously, expression of
this subset of genes does not prove that MAPCs are more
closely related to ESCs than to MSCs at the global transcrip-
tional level. However, this analysis provides a list of candidate
regulators of MAPC self-renewal that will need to be validated
using functional studies to elucidate their role in self-renewal
and differentiation potential of adult stem cells.
MAPCs do not, however, express a key transcription factor for
E S C  p l u r i p o t e n c y  -  N a n o g .  D u r i n g  d e v e l o p m e n t ,  l o s s  o f
Nanog expression from cells that express Oct4 is associated
with the expression of Gata6 and restriction of cells in the
ICM to primitive endoderm [33]. Sall4, a gene recently found
to directly regulate Oct4 expression in ESCs and which is
involved in epiblast and primitive endoderm specification in
vivo, is highly expressed in MAPCs [36,37]. Consistent with
these known molecular interactions, we show here that the
transcriptome of mouse and rat MAPCs resembles that of
extraembryonic endoderm cell lines, parietal endoderm, and
visceral endoderm [29]. However, MAPCs also express a
number of mesodermal, and to a lesser extent ectodermal,
transcripts. Remarkably, a similar conclusion can be drawn
when MAPCs are compared with ESCs and NS, or to ESCs
only, using a distinct microarray platform and clustering
algorithm. It should be noted that despite the fact that
mMAPCs do not express Nanog, MAPCs express 84 genes
that are presumed transcriptional targets in ESCs for Nanog
alone or both Nanog and Oct4 [53]. Whether the absence of
Nanog expression in mMAPCs might be compensated for by
transcription factor activity of Stat3, Mycn, Klf4, Klf5, and
Klf8, which bind to some of the Nanog target genes, will need
to be determined. The classification of MAPCs, MSCs, and
ESCs by PCA and NMF using their respective transcriptomes
thus correlates with their differentiation capacity.
More important, this study demonstrates for the first time
that clonal isolation under identical conditions can yield cells
with transcriptional and functional characteristics of MAPCs
or cells with characteristics of MSCs. Although the analysis
cannot answer the question of whether MAPCs exist in bone
marrow or are a culture-induced phenomenon, we show that
genes found to be more highly expressed in ESCs or MSCs fol-
lowing short-term exposure to hypoxia [51,52] are not simi-
larly upregulated in cells isolated and cultured under MAPC
conditions; hence acute hypoxia-responsive genes are not
responsible for differences in the transcriptomes of MAPCs
and either MSCs or ESCs. Furthermore, no change in cell-sur-
face phenotype, or expression of Oct4  or other genes
expressed at significantly higher levels in MAPCs compared
with MSCs, was seen when cells isolated and characterized as
MSCs were cultured for 14 days in MAPC culture conditions.
It should be noted that the gene for one of the PDGF recep-
tors, namely Pdgfra, which is not expressed in MSCs, is
expressed in mClone-3 at levels near those found in
mMAPCs, but was not induced in MSCs maintained for 14
days under MAPC conditions. This might suggest that isola-
tion and/or long-term maintenance of cells under the specific
MAPC culture conditions, rather than MSC conditions, may
influence the transcriptome. However, we demonstrated that
only 146 genes were highly correlated or anti-correlated with
Pdgfra. Removal of this set of genes from the dataset did not
influence the clustering of MAPCs, MSCs, and ESCs by either
NMF or PCA, further demonstrating that differences between
MSCs and MAPCs are not simply the result of differences in
culture conditions.
One possible explanation for the isolation of MAPC-like or
MSC-like cells, is that apart from MSCs, the more pluripotent
Oct4-positive stem cells remain in the bone marrow during
development, as suggested by Kucia et al. [18] and Anjos-
Afonso and Bonnet [13]. However, the CD45-Lin- Sca1+ cells
i d e n t i f i e d  i n  b o n e  m a r r o w  b y  K u c i a  et al. [18] coexpress
Nanog mRNA and protein, and express significantly lower
levels of endodermal as well as mesodermal and ectodermal
transcripts. The SSEA1+ CD45- Lin- CD31- population sorted
directly from bone marrow by Anjos-Afonso and Bonnet [13]
also express Oct4  and  Nanog  mRNA and protein. Like
MAPCs, these cells differentiated at the clonal level into cells
Genes for proteins localized to the extracellular space and for transcriptional regulators clustered according to expression profiles in MAPC/ESC/NS  comparison Figure 6 (see previous page)
Genes for proteins localized to the extracellular space and for transcriptional regulators clustered according to expression profiles in MAPC/ESC/NS 
comparison. (a, b) Genes expressed at levels at least twofold higher in both MAPCs and ESCs than in NS (k-means clusters 2 and 4). (c, d) Genes 
expressed in MAPCs at levels at least twofold higher than in both ESCs and NS (k-means cluster 3). The yellow bars indicate genes whose products are 
localized to the extracellular space; the blue bars indicate genes for transcriptional regulators. Red and green indicate higher and lower levels of 
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of the three germ layers in vitro and to multiple mesodermal
cell types in vivo. It should be noted that only when MAPC
culture conditions were used could the cell phenotype and
differentiation capabilities be maintained in vitro. The prim-
itive endoderm-like phenotype of MAPCs may be explained
by heterogeneous expression of Oct4 and Nanog in cells from
bone marrow, or by their prolonged expansion in the pres-
ence of PDGF and EGF in the culture medium. MAPCs
express the tyrosine kinase receptor Pdgfra, which is
expressed in primitive endoderm in mouse embryos before
gastrulation [54]. Numerous transcriptional targets of PDGF
signaling were discovered by Chen et al. [55]. Some of these
target genes (Tead4, Kit, CD9, Gfpt1, and Mrpl38) were more
highly expressed in MAPCs than ESCs, MSCs, or NS.
It is also possible that the in vitro culture and clonal expan-
sion under the conditions described here induces reprogram-
ming or dedifferentiation of s t e m  c e l l s  i n  b o n e  m a r r o w .
However, the finding that MSC-like cells that do not express
Oct4 are also isolated under these conditions from mouse and
rat indicates that not all bone marrow cells can be
reprogrammed.
Conclusion
Regardless of their origin, the isolation of cells with pluripo-
tent capacity from postnatal somatic tissues yields another
source of stem cells to study and to compare self-renewal and
differentiation mechanisms in stem cells, in cell-based thera-
pies, or in vitro drug screening. Here we demonstrate by
using multivariate analysis of gene-expression data that
MAPCs are different from MSCs and ESCs at the global tran-
scriptome level and that their expressed gene profile strongly
correlates with their in vitro differentiation capacity, as they
express transcripts of early endoderm and mesoderm.
MAPCs also express a subset of ESC-associated transcripts,
some of which are known to play a role in the maintenance
and self-renewal of ESCs. MAPCs, however, do not express
Nanog or Sox2, two key transcription factors in the ESC
pluripotency network. Future knockdown and overexpres-
sion studies will be needed to demonstrate that expression of
genes known to impart pluripotency in ESCs are responsible
for the broader differentiation capacity of MAPC compared
with other adult stem cells. The molecular characterization of
MAPCs compared with multipotent stem cells as well as ESCs
should aid significantly in the future prospective isolation and
culture of more pluripotent adult stem cells. This study
should also allow the cross-comparison of different adult
stem-cell populations with presumed broader differentiation
ability, in order to elucidate the genes that confer these prop-
erties on them.
Materials and methods
Cell culture and RNA collection for gene arrays
C57BL/6 mice carrying the gene for enhanced green fluores-
cent protein (eGFP) were provided by I.L. Weissman (C57BL/
6-Tg-eGFP) and by M. Okabe, Osaka University, Japan
(C57BL/6TgN (act-EGFP) ObsC14-Yo1-FM1310 mice).
MAPCs were isolated as described by Breyer et al. [14].
Briefly, bone marrow was plated in 60% low glucose DMEM
(Gibco BRL, Grand Island, NY), 40% MCDB-201 (Sigma, St
Louis, MO) containing 10 ng/ml mEGF (Sigma), hPDGF-BB
(R&D Systems, Minneapolis, MN) and 1000 units/ml mLIF
PCA and NMF analysis on the gene-expression data of MSC, MSC-like (MSC-l, mClone-3), MAPC-1 (M-1), MAPC-2 (M-2) and ESC Figure 7
PCA and NMF analysis on the gene-expression data of MSC, MSC-like (MSC-l, mClone-3), MAPC-1 (M-1), MAPC-2 (M-2) and ESC. (a) PCA on all 
differentially expressed genes with samples plotted in the first two components' space. (b) Consensus matrix from NMF on all differentially expressed 
genes. See Figure 3 for an explanation of the key in (b).
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(Chemicon International, Temecula, CA), 2% screened FCS
(Hyclone, Logan, UA, Lot ANL19977), 1 × selenium-insulin-
transferrin-ethanolamine (SITE), 0.2 mg/ml linoleic acid-
bovine serum albumin (LA-BSA), 0.8 mg/ml BSA (all from
Sigma), 1 × chemically defined lipid concentrate (Gibco) and
55 μM 2-mercaptoethanol (Gibco), 100 units of penicillin,
1,000 units of streptomycin (Cellgro, Herndon, VA) in a
humidified, 5% O2 and 6% CO2, 37°C incubator. After 4
weeks, CD45+ and Ter119+ cells were depleted using a MACS
separation CS column (Miltenyi Biotec, Auburn, CA), and
cells replated at 10 cells/well. Expansion was done by
trypsinizing (0.05% trypsin, Cellgro) the cells and replating
them every 2 days at a density of 100-200 cells/cm2. Cells at
population doubling of more than 80 were used for three
RNA collections for gene arrays and differentiation assays
which were done over a span of 10 passages (25 to 30 popula-
tion doublings). MAPC-1 and MSC-like cells were generated
from C57Bl/6TgN (act-EGFP) ObsC14-Yo1-FM1310 mice and
MAPC-2 from C57Bl/6-Tg-eGFP mice.
Mouse MSCs (C57BL/6) passage 5 were obtained from the
Tulane University Center for Gene Therapy where they were
isolated and shown to differentiate into bone and fat cells as
described by Peister et al. [22]. They were thawed and cul-
tured using medium and serum as recommended by the
center and as described by Peister et al. [22]. Briefly, cells
were cultured at a plating density of 100 cells/cm2 in IMDM
(Gibco) with 2 mM L-glutamine (Gibco), 100 U/ml penicillin,
100 μg/ml streptomycin, 0.25 μg/ml amphotericin B (Gibco),
10% screened FBS (Atlanta Biologicals, Lawrenville, GA, Lot
C0105) and 10% equine serum (Hyclone, Lot AQH24495) in
a humidified, 21% O2, 5% CO2, 37°C incubator. As recom-
mended, a first passage was done 1 day after thawing and sub-
sequently cells were passaged every 6 days. RNA samples for
gene arrays were taken 3 days after passaging with plates
seeded at 300 cells/cm2 during three consecutive passages
(10 population doublings).
Mouse ESCs (C57BL/6) passage 12 were maintained on irra-
diated mouse embryonic fibroblasts (MEFs) in high glucose
DMEM with sodium pyruvate (Gibco), 15% FBS (Hyclone;
Lot ANC18367), 2 mM L-glutamine, 100 units of penicillin,
1,000 units of streptomycin, 100 μM 2-mercaptoethanol and
1,000 units/ml mLIF in a humidified, 21% O2, 5% CO2, 37°C
incubator. Cells were passaged every 2 days and RNA for gene
arrays was collected during three passages (12 population
doublings) from ESCs plated without MEFs.
Neuroepithelial cells were isolated from the forebrains of
E11.5 C57BL/6 embryos by dissecting telencephalons and dis-
sociating them into a near single-cell suspension in DMEM
media. Approximately 1-2 × 105 cells were plated into 6-well
plates containing DMEM/F-12 (Gibco) and N-2 plus medium
(R&D Systems) supplemented with 20 ng/ml mEGF and
mFGF-2 (R&D Systems). Neurospheres (NS) were passaged
every 4 days by centrifuging for 5 min at 40 g and partially
dissociating the NS by pipetting up and down. Total RNA was
prepared from passage 2 NS (eight population doublings).
Rat MAPCs were isolated as described [14]. Briefly, Fisher rat
BM cells were plated on 60% low-glucose DMEM, 40%
MCDB-201, 1 × insulin-transferrin-selenium (ITS, Sigma), 1
× LA-BSA, 0.05 × 10-6 M dexamethasone (Sigma), 10-4 M
ascorbic acid 3-phosphate, 100 units penicillin, 1,000 units
streptomycin, 55 μM 2-mercaptoethanol, 2% FBS (HyClone;
Lot ANL19977), 10 ng/ml hPDGF-BB, 10 ng/ml mEGF, and
1,000 units/ml mLIF in a humidified, 5% O2 and 6% CO2,
37°C incubator. After 4 weeks, CD45+ cells were depleted
using a MACS separation CS column, and cells replated at 10
cells/well. Expansion was done by trypsinizing (0.05%
trypsin) the cells and replating them every 2 days at a density
of 200 cells/cm2. Cells at population doubling grater than100
were used for three RNA collections for gene arrays (20 pop-
ulation doublings).
Cell surface phenotype and intracellular Oct4 staining
Cell-surface phenotype
Cells were collected by trypsinization, washed with PBS con-
taining 3% FBS, and blocked for 10 min with 5% rat serum
and anti-CD16/CD32 antibody. After washing, cells were
incubated for 30 min at 4°C in 3% FBS containing conjugated
antibodies. Cells were washed once and resuspended in PBS
3% FBS plus propidium iodide and analyzed by flow
cytometry.
Antibodies for mouse cell-surface markers were: CD45-APC,
Sca1-PE, CD44-PE, c-Kit-APC, CD140a-APC (eBioscience,
San Diego, CA), CD34-APC (eBioscience). Antibodies for rat
cell-surface markers were CD44-PE and CD31-FITC (all
antibodies except indicated otherwise were from BDP-
harmingen, San Diego, CA).
Intracellular Oct4 staining
Cells were collected by trypsinization, washed twice with PBS
and fixed in 4% paraformaldehyde for 10 min at room tem-
perature. After washing twice with PBS, cells were permeabi-
lized with 0.1% (w/v) saponin (Sigma), 0.05% (w/v) sodium
azide in PBS (SAP buffer) and blocked for 5 min in SAP buffer
plus 10% donkey serum. After blocking, cells were incubated
for 15 min at room temperature in SAP buffer plus anti-Oct3/
4 antibody clone N19 (Santa Cruz Biotechnology, Santa Cruz,
CA) and washed twice with SAP buffer. Cells were incubated
for 15 min at room temperature with secondary antibody Cy5-
labeled anti-goat (Jackson Immunoresearch, West Grove,
PA) diluted in SAP buffer, washed twice with SAP buffer and
resuspended in PBS for analysis by flow cytometry.
Karyotyping
Two days after cells were seeded, they were exposed to 0.1 μg/
ml colcemid (Sigma) for 3 h, harvested, washed, and exposed
to 75 mM KCl hypotonic solution for 5 min. Hypotonic solu-
tion was washed out by centrifugation and cells were fixed inR163.16 Genome Biology 2007,     Volume 8, Issue 8, Article R163       Ulloa-Montoya et al. http://genomebiology.com/2007/8/8/R163
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10 ml methanol/acetic acid (3:1) fixative for 5 min. Fixed cells
were collected by centrifugation and resuspended in 0.2 ml
methanol/acetic acid (3:1) fixative. Cells were dropped onto a
hot glass slide. Chromosomes were stained using Wright's
stain. Twenty chromosomal spreads were counted per
population.
MAPC differentiations
Endothelial differentiation
Mouse and rat MAPCs, as well as mClone-3 and rClone-2,
were plated on day 0 in their respective growth medium at
60,000 cells/cm2 on fibronectin-coated 12-well plates. On
day 1, medium was switched completely to differentiation
medium in low-glucose DMEM/MCDB-201 (60:40) contain-
ing 10 ng/ml hVEGF-A (R&D Systems), 1 × ITS, 1 × LA-BSA,
10-8 M dexamethasone, 10-4 M ascorbic acid 3-phosphate, 100
units penicillin, 1,000 units streptomycin and 55 μM 2-mer-
captoethanol. For mouse MAPCs, differentiations were done
in the absence of FCS. For rat MAPCs, FCS was maintained at
2%. RNA samples were collected on day 9 for analysis.
Liver differentiation
Mouse and rat MAPCs, as well as mClone-3 and rClone-2,
were plated at 50,000 cells/cm2 on matrigel-coated 12-well
plates using low-glucose DMEM/MCDB-201 (60:40) con-
taining 2% FBS, 0.25 × ITS, 0.5 × LA-BSA, 0.1 × 10-6 M dex-
amethasone, 10-4 M ascorbic acid 3-phosphate, 100 units
penicillin, 1,000 units streptomycin, and 55 μM 2-mercap-
toethanol. The growth factor used varied over time: 50 ng/ml
hBMP-4 and 10 ng/ml hFGF2 from day 1 to day 6, 10 ng/ml
mFGF-8b and 10 ng/ml hHGF from day 6 to day 9; and 10 ng/
ml human oncostatin M and 10 ng/ml hHGF from day 9 to
day 18 (all cytokines and growth factors from R&D systems).
A 75% media change was done every 3 days and RNA samples
were collected on day 18.
Neuroectoderm differentiation
Rat or mouse MAPCs were plated at 1,500/cm2 and 2000/
cm2, respectively, on fibronectin-coated glass coverslips
placed in a 6-well plate; the medium used was Neurobasal-A
medium and DMEM/F12 (1:1) supplemented with B27
(0.5×), N2plus (0.5×), BME (0.1 mM) and L-glutamine (0.2
mM). A 60% medium change was performed every other day
and RNA samples were collected on day 7.
RNA isolation and Q-RT-PCR
Total RNA from undifferentiated and differentiated cells was
extracted using the RNeasy microkit (Qiagen, Valencia, CA).
mRNA was reverse transcribed using Superscript III reverse
transcriptase (Invitrogen, Carlsbad, CA) and cDNA under-
went 40 rounds of amplification (ABI PRISM 7700, Perkin
Elmer/Applied Biosystems, Foster City, CA) as follows: 40
cycles of a two-step PCR (95°C for 15 sec, 60°C for 60 sec)
after initial denaturation (95°C for 10 min) with 1 μl DNA
solution, 1 × TaqMan SYBR Green Universal Mix PCR reac-
tion buffer (Applied Biosystems). Primers used for amplifica-
tion are shown in Table 1. mRNA levels were normalized
using the housekeeping gene GAPDH  and compared with
mRNA levels in mouse universal RNA (Ambion, Austin, TX),
Fisher rat spleen for endothelial-like differentiation, mouse
hepatocytes (Ambion) or Fisher rat total liver for hepatocyte-
like differentiation, and mouse embryonic brain E15 RNA or
rat embryonic brain E17 RNA (both from Gentaur, Brussels,
Belgium) for neuroectoderm differentiations.
Affymetrix microarray sample and data processing
Samples of 100 ng of total cellular RNA isolated from mouse
MSCs, mClone-3, mMAPC-1 and -2, and ESCs were double
amplified and labeled with the Two-Cycle Target Labeling
and Control Reagents kit P/N 900494 (Affymetrix, Santa
Clara, CA) following the manufacturer's protocol. Samples of
200 ng of total cellular RNA from rat rMAPC-1 and rClone-2
were double amplified and labeled to generate labeled cRNA
for hybridization. The first round of in vitro transcription-
based, linear amplification was performed using the Ribo-
Amp OA RNA Amplification Kit (Arcturus, Mountain View,
CA) followed by labeling with the Enzo Bioarray HighYield
RNA Transcript Labeling Kit (Enzo Diagnostics,
Farmingdale, NY) according to the manufacturers' instruc-
tions. Samples were hybridized to Affymetrix mouse 430 2.0
chips or rat Expression Set 230A chips, washed, and scanned
at the University of Minnesota Affymetrix Microarray Core
Facility as described in the Affymetrix GeneChip Expression
Analysis Technical Manual. CEL files were loaded into Gene-
Data Expressionist Refiner (GeneData, San Francisco, CA) to
assess overall quality and obtain condensed single intensity
values per probe set using the Microarray Analysis Suite Sta-
tistical algorithm (MAS 5.0). The mean of mean intensity val-
ues for all chips was used to normalize the mean intensity of
each chip. A probe set intensity value threshold of 20 and 25
for mouse and rat chips, respectively, was determined in
GeneData Expressionist Analyst according to the absent/
present calls from MAS 5.0. The average of the expression
levels from the three replicates were used for further analysis.
Probes with at least twofold differential expression in one
group with respect to any other group were considered as dif-
ferentially expressed. The statistical significance of differen-
tial expression was determined using SAM [23]. Probes were
annotated using the Web-based Affymetrix NetAffx analysis
tool [56] and Ingenuity Pathway Analysis (Ingenuity, Moun-
tain View, CA).
NIA microarray sample and data processing
Total RNA was extracted from mMAPC-1, ESCs, and neuro-
spheres using Trizol reagent (Invitrogen). ESCs were pas-
saged for a short time on gelatin-coated dishes to remove
feeder cells. Samples of 2.5 μg total RNA from MAPCs, ESCs,
and NS were labeled with Cy3-CTP dye and a universal mouse
reference RNA (Stratagene, La Jolla, CA) was labeled with
Cy5-CTP dye using a fluorescent linear amplification kit (Agi-
lent Technologies, Palo Alto, CA) [57]. Two biological repli-
cates were used for hybridizations. cRNA from MAPCs, ESCs,http://genomebiology.com/2007/8/8/R163 Genome Biology 2007,     Volume 8, Issue 8, Article R163       Ulloa-Montoya et al. R163.17
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and NS was added to a universal reference cRNA and hybrid-
i z e d  t o  a  N I A  M o u s e  4 4  K  M i c r o a r r a y  v 2 . 1  s l i d e  ( W h o l e
Genome 60-mer oligo; Agilent 012799). Microarrays were
hybridized and washed following Agilent protocol G4140-
90030 (Agilent 60-mer oligo microarray processing protocol;
SSC Wash, V1.0) and scanned using an Agilent DNA microar-
ray scanner. Images from scanned microarrays were analyzed
for feature intensity using Agilent Feature Extractor A7.5.1
software [57]. Cy3-CTP-labeled MAPC, ESC, and NSC cRNA
samples were normalized to Cy5-CTP labeled universal refer-
ence cRNA. NIA Array Analysis Tool software [58] was used
for analysis of variance (ANOVA), averaging of replicates, and
Table 1
Primers used for determination of mRNA expression levels by Q-RT-PCR
Gene Forward primer Reverse primer
Mouse
Gapdh TGCACCACCAACTGCTTAG GATGCAGGGATGATGTTC
Oct4 (Pou5f1) CCAATCAGCTTGGGCTAGAG CCTGGGAAAGGTGTCCTGTA
Pecam GTCATGGCCATGGTCGAGTA CTCCTCGGCGATCTTGCTGAA
Lyve-1 AGGAGCCCTCTCCTTACTGC ACCTGGAAGCCTGTCTCTGA
vWF GCCAAAGATCTGGAACAGTGT GATGGAGAGGTTACACATCTC
F2 CAGCTATGAGGAGGCCTTTG TCACACCCAGATCCATAGCA
Tat TTAAGTCCAATGCGGACCTC GCTCTGTGAATTCCACGTCA
Afp GCCCTACAGACCATGAAACAAG GTGAAACAGACTTCCTGGTCCT
Ttr CTTTGCCTCTGGGAAGACC CAGAGTCGTTGGCTGTGAAA
Foxa2 CCCGGGACTTAACTGTAACG TCATGTTGCTCACGGAAGAG
Hnf4a GGTCAAGCTACGAGGACAGC ATGTACTTGGCCCACTCGAC
Sox7 CTTCAGGGGACAAGAGTTCG CCATGACTTTCCCAGCATCT
Sox17 CACAACGCAGAGCTAAGCAA TTGTAGTTGGGGTGGTCCTG
Myocd CTGTGTGGAGTCCTCAGGTCAAACC GATGTGTTGCGGGCTCTTCAG
Pdgra ACGTTCAAGACCAGCGAGTT CCTCCAGCATGGTGATACCT
Pdgfrb CACCTTCTCCAGTGTGCTGA GGAGTCCATAGGGAGGAAGC
Tek AAGCATGCCCATCTGGTTAC GCCTGCCTTCTTTCTCACAC
Fbx15 GGCCTTGAATGGAGAACTGA TCAAACCACCCTAGGTCTGC
Dnmt3l CCTGGTGAAGAACTGCCTTC GCAAAGTGAGCTGCACAGAG
Rex1 CCTGCACACAGAAGAAAGCA TCAGTCTGTCGAGGGCTCTT
Dppa5 CAGTCGCTGGTGCTGAAATA TCCATTTAGCCCGAATCTTG
Eras CCCTGCTTGTCCATGAGATT TGGTAACTTGGTCGGAGAGG
Utf1 GGCCATACCTTCGAATCCTC GGTTTGGTCGAAGGAACCTC
Tdgf1 GCATCCTACGAGGGAGTTGA CACTGTGCTTGGCTGAAGAA
Tcl1 TTCCTCTCTGGGTGTTCAGG ATCCCACACATTCCCTTTCA
Ecat1 GAATGCCTGGAAGATCCAAA AAATCTCAGCTCGCCTTTCA
Nanog GAGTGTGGGTCTTCCTGGTC GAGGCAGGTCTTCAGAGGAA
Gdf3 CGCAGGACTTATGCTACGTG CTGGGCCATGGTCAACTT
Fgf4 CCGACGAGTGTAAATTCAAAGAA GGAAGTGGGTTACCTTCATGG
Sox2 ACCAGCTCGCAGACCTACAT AGTGGGAGGAAGAGGTAACCA
Sox1 CACAACTCGGAGATCAGCAA TGTAATCCGGGTGTTCCTTC
Pax6 TCAGACCTCCTCATACTCGTGCA TGTAGGTATCATAACTCCGCCCA
Rat
Gapdh TGCACCACCAACTGCTTAG GATGCAGGGATGATGTTC
Oct4 (Pou5f1) CTGTAACCGGCGCCAGAA TGCATGGGAGAGCCCAGA
Vecad GGCCAACGAATTGGATTCTA GTTTACTGGCACCACGTCCT
Flt-1 TGGCCAGAGGCATGGAGT TCGCAAATCTTCACCACATTG
Flk-1 CCAAGCTCAGCACACAAAAA CCAACCACTCTGGGAACTGT
vWF CCCACCGGATGGCTAGGTATT GAGGCGGATCTGTTTGAGGTT
Afp ACCTGACAGGGAAGATGGTG GCAGTGGTTGATACCGGAGT
Alb CTGGGAGTGTGCAGATATCAGAGT GAGAAGGTCACCAAGTGCTGTAGT
Tat AACCTCAGCACCAATGTTCC TCTTCAGAGCACCCTGGACT
Ttr CAGCAGTGGTGCTGTAGGAGTA GGGTAGAACTGGACACCAAATC
Sox2 AACCCCAAGATGCACAACTC CCGGGAAGCGTGTACTTATC
Otx1 GTTCGCAAAGACTCGCTACC CCGGAGACGACTTCTTCTTG
Blbp CCAGCTGGGAGAAGAGTTTG TTTCTTTGCCATCCCACTTC
Pax6 GTCCATCTTTGCTTGGGAAA TAGCCAGGTTGCGAAGAACTR163.18 Genome Biology 2007,     Volume 8, Issue 8, Article R163       Ulloa-Montoya et al. http://genomebiology.com/2007/8/8/R163
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annotation of probe IDs. A twofold difference in expression
between one sample and any other sample was considered
significant.
Sample- and gene-clustering algorithms
The log-transformed and mean-centered intensity values of
significant differentially expressed genes were utilized in PCA
using software from Spotfire (Spotfire, Cambridge, MA)
based on the algorithm described by Alter et al. [24]. NMF
and consensus matrix were applied to the log-transformed
intensity values of significant differentially expressed genes
in the Affymetrix dataset using the algorithms implemented
by Brunet et al. for Matlab [26]. Gene clustering was
performed by calculating the correlation coefficients of each
gene to metagenes, and genes were assigned as correlated to
a metagene profile if the correlation coefficient was greater
than 0.75 or anti-correlated if it was smaller than -0.75. Pro-
file correlation coefficients to Pdgfra  were calculated on
genes with consistent twofold differential expression among
MAPC (group 1) and non-MAPC (group 2) condition culture
samples (for example, each sample from group 1 vs each
sample from group 2). Owing to the nature of the two-channel
data obtained from the NIA microarray, we decided to per-
form k-means clustering on this dataset [59] instead of NMF.
This was done on log-transformed and mean-centered inten-
sity values of differentially expressed genes using Spotfire.
The raw and processed microarray data in this paper have
been deposited in the Gene Expression Omnibus (GEO) data-
base [60] and have been assigned the accession numbers
GSE5947 and GSE6933.
Additional data files
The following additional data are available with this paper
online. Additional data file 1 contains 14 tables that list vari-
ous aspects of the stem-cell transcriptomes: supplementary
Table 1 lists genes expressed in MAPC at levels at least two-
fold higher than in MSC and ESC; supplementary Table 2 lists
genes expressed in MAPC and ESC at levels at least twofold
higher than in MSC; supplementary Table 3 lists genes
expressed in MAPC and MSC at levels at least twofold higher
than in ESC; supplementary Table 4 lists genes expressed in
MAPC at levels at least twofold higher than in ESC and NS;
supplementary Table 5 lists genes expressed in MAPC and
ESC at levels at least twofold higher than in NS; supplemen-
tary Table 6 lists genes expressed in MAPC at levels at least
twofold higher than in ESC in NIA microarrays; supplemen-
tary Table 7 lists genes expressed in ESCs at levels at least
twofold higher than in MAPC in NIA microarrays; supple-
mentary Table 8 contains a MAPC gene cluster comparison
between Affymetrix and NIA microarrays; supplementary
Table 9 lists genes differentially expressed between MSCs and
MSC-like cells; supplementary Table 10 lists genes correlated
with Pdgfra with twofold differential expression between all
MAPC conditions cultured cells vs ESCs and MSCs; supple-
mentary Table 11 lists genes anti-correlated to Pdgfra with a
twofold differential expression between all MAPC conditions
cultured cells vs ESCs and MSCs; supplementary Table 12
lists genes with at least twofold higher expression in rMAPC-
1 than in rClone-2; supplementary Table 13 lists genes with at
least twofold higher expression in rClone-2 than in rMAPC-1;
supplementary Table 14 lists common differentially
expressed genes in both mMAPC vs MSC and rMAPC-1 vs
rClone-2 comparisons. Additional data file 2 contains three
figures showing analyses of hypoxic and Pdgfra correlated
genes and correlation between mouse and rat MAPC
expressed gene profile.: supplementary Figure 1 shows PCA of
MSC, MSC-like (MSC-l, mClone-3), MAPC-1 (M-1), MAPC-2
(M-2) and ESC on reported ESC and MSC hypoxia upregu-
lated genes; supplementary Figure 2 shows PCA and NMF
analysis of MSC, MSC-like (MSC-l, mClone-3), MAPC-1 (M-
1), MAPC-2 (M-2) and ESC on differentially expressed genes
minus genes correlated or anticorrelated to Pdgfra; supple-
mentary Figure 3 shows the correlation of fold difference on
common differentially expressed genes between mMAPCs vs
MSCs and rMAPC-1 vs rClone-2.
Additional data file 1 14 tables that list various aspects of the stem-cell transcriptomes Supplementary Table 1 lists genes expressed in MAPC at levels at  least twofold higher than in MSC and ESC; supplementary Table 2  lists genes expressed in MAPC and ESC at levels at least twofold  higher than in MSC; supplementary Table 3 lists genes expressed in  MAPC and MSC at levels at least twofold higher than in ESC; sup- plementary Table 4 lists genes expressed in MAPC at levels at least  twofold higher than in ESC and NS; supplementary Table 5 lists  genes expressed in MAPC and ESC at levels at least twofold higher  than in NS; supplementary Table 6 lists genes expressed in MAPC  at levels at least twofold higher than in ESC in NIA microarrays;  supplementary Table 7 lists genes expressed in ESCs at levels at  least twofold higher than in MAPC in NIA microarrays; supplemen- tary Table 8 contains a MAPC gene cluster comparison between  Affymetrix and NIA microarrays; supplementary Table 9 lists  genes differentially expressed between MSCs and MSC-like cells;  supplementary Table 10 lists genes correlated with Pdgfra with  twofold differential expression between all MAPC conditions cul- tured cells vs ESCs and MSCs; supplementary Table 11 lists genes  anti-correlated to Pdgfra with a twofold differential expression  between all MAPC conditions cultured cells vs ESCs and MSCs;  supplementary Table 12 lists genes with at least twofold higher  expression in rMAPC-1 than in rClone-2; supplementary Table 13  lists genes with at least twofold higher expression in rClone-2 than  in rMAPC-1; supplementary Table 14 lists common differentially  expressed genes in both mMAPC vs MSC and rMAPC-1 vs rClone- 2 comparisons. Click here for file Additional data file 2 A file containing three figures showing analyses of hypoxic and  Pdgfra correlated genes and correlation between mouse and rat  MAPC expressed gene profile. Supplementary Figure 1 shows PCA of MSC, MSC-like (MSC-l,  mClone-3), MAPC-1 (M-1), MAPC-2 (M-2) and ESC on reported  ESC and MSC hypoxia upregulated genes; supplementary Figure 2  shows PCA and NMF analysis of MSC, MSC-like (MSC-l, mClone- 3), MAPC-1 (M-1), MAPC-2 (M-2) and ESC on differentially  expressed genes minus genes correlated or anticorrelated to Pdg- fra; supplementary Figure 3 shows the correlation of fold difference  on common differentially expressed genes between mMAPCs vs  MSCs and rMAPC-1 vs rClone-2. Click here for file
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